DRIO - weekly frameEarning after the close on 3/21/22...expecting short term bear move near 5.60 with possible long term bull
−1.96USD
−54.86 MUSD
20.35 MUSD
23.91 M
About DarioHealth Corp.
Sector
Industry
CEO
Erez Raphael
Website
Headquarters
New York
Employees (FY)
276
Founded
2011
FIGI
BBG003V5P7K2
DarioHealth Corp. is a digital health company which offers a user-centric and multi-chronic condition digital therapeutics platform that delivers personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. DarioHealth serves customers globally. The company was founded by Oren Fuerst, Shoshana Friedman, David Weintraub, Dov Oppenheim, and Shilo Ben Zeev on August 11, 2011 and is headquartered in New York, NY.
DarioHealth Announces Three New Contracts as Growth Continues toDRIO: DarioHealth Corp.
2021-11-11 06:40:00
DarioHealth Announces Three New Contracts as Growth Continues to Accelerate Across the Employer and Provider Markets
DRIO. Stay above 26.20, can Test 32 and run to ATH againLong DRIO, Small Cap.
Stop at 26.20 (Close Price Only)
Potentially look to add over 32
TDOC, enters Downtrend as Momentum drops below 0 level on Feb 22This indicator may be signaling that TDOC's price has further to drop, since it fell below its price logged 14 days ago. Traders may consider selling the stock, shorting the stock, or exploring put options. A.I.dvisor backtested 82 similar cases where TDOC's Momentum Indicator fell below the 0 level
DRIO, MACD Histogram just turned negativeThis is a Bearish indicator signaling DRIO's price could decline from here. Traders may explore shorting the stock or put options. Tickeron's A.I.dvisor identified 51 similar cases where DRIO's MACD histogram became negative, and 42 of them led to successful outcomes. Odds of Success: 82%. Current p
Announces $28.6 Million Private PlacementDarioHealth Announces $28.6 Million Private Placement
closed a private placement transaction with accredited investors, including healthcare funds and institutions from the U.S. and Israel
pre-funded warrants to purchase 824,689 shares of common stock at an exercise price of $0.0001 per share. The
DarioHealth Corp. Breakout watch DarioHealth Corp. is a digital therapeutics company, which engages in the research, development, and sale of pharmaceutical products. It offers a monitoring device, mobile application, and data services for diabetes management. Its solutions include MyDario, Daro Engage, and Dario Intelligence. The
pennies to thousands new stock candidategood volume new stock no overhead supply
relative strength good
upper bands on cci and percent r
money supply increasing
candle had wick wait for good opening candle see our book on amazon for entry rules
See all ideas
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of DRIO is 1.32 USD — it has increased by 13.79% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange DarioHealth Corp. stocks are traded under the ticker DRIO.
DarioHealth Corp. is going to release the next earnings report on May 13, 2024. Keep track of upcoming events with our Earnings Calendar.
DRIO stock is 18.69% volatile and has beta coefficient of 2.19. Check out the list of the most volatile stocks — is DarioHealth Corp. there?
One year price forecast for DarioHealth Corp. has a max estimate of 8.00 USD and a min estimate of 4.00 USD.
DRIO earnings for the last quarter are −0.49 USD per share, whereas the estimation was −0.52 USD resulting in a 5.77% surprise. The estimated earnings for the next quarter are −0.39 USD per share. See more details about DarioHealth Corp. earnings.
DarioHealth Corp. revenue for the last quarter amounts to 3.52 M USD despite the estimated figure of 5.42 M USD. In the next quarter revenue is expected to reach 3.78 M USD.
Yes, you can track DarioHealth Corp. financials in yearly and quarterly reports right on TradingView.
DRIO stock has risen by 10.00% compared to the previous week, the month change is a 10.20% fall, over the last year DarioHealth Corp. has showed a 63.93% decrease.
DRIO net income for the last quarter is −12.00 M USD, while the quarter before that showed −14.20 M USD of net income which accounts for 15.46% change. Track more DarioHealth Corp. financial stats to get the full picture.
Today DarioHealth Corp. has the market capitalization of 34.15 M, it has increased by 7.52% over the last week.
No, DRIO doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, DRIO shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade DarioHealth Corp. stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 23, 2024, the company has 276.00 employees. See our rating of the largest employees — is DarioHealth Corp. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So DarioHealth Corp. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating DarioHealth Corp. stock shows the sell signal. See more of DarioHealth Corp. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on DarioHealth Corp. future price: according to them, DRIO price has a max estimate of 8.00 USD and a min estimate of 4.00 USD. Read a more detailed DarioHealth Corp. forecast: see what analysts think of DarioHealth Corp. and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. DarioHealth Corp. EBITDA is −50.84 M USD, and current EBITDA margin is −249.79%. See more stats in DarioHealth Corp. financial statements.